Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint research program to create an AI-based pathology diagnostic tool at the 20th annual ...
Medical Device Network on MSN
HMS-led team develops AI tool to differentiate brain cancer types
"HMS-led team develops AI tool to differentiate brain cancer types" was originally created and published by Medical Device Network, a GlobalData owned brand.
Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model that is capable of performing an array of diagnostic tasks across multiple forms of cancers. The researchers, ...
A new study that analyzed protein levels in 2,002 primary tumors from 14 tissue-based cancer types identified 11 distinct molecular subtypes, providing systematic knowledge that greatly expands a ...
CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking the power of pathology data, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback